Caring for Children on COG AML protocols: Quick Hits and Nursing Tips (C205)
Acute myeloid leukemia (AML) is the second most common form of leukemia in children, and the intensive therapy used to treat pediatric AML requires expert nursing knowledge.
The rate of event-free survival for childhood AML is estimated to be 55%, and intensification of current chemotherapy protocols is not possible because of the treatment’s known toxicity profile, which includes cardiotoxicity and infectious toxicity. The Children’s Oncology Group (COG) is working to improve the survival of pediatric AML patients through advances in risk stratification and new chemotherapy formulations, targeted therapies, and supportive care strategies. In this session, we will review the current COG protocols for children with newly diagnosed AML, AAML1831 (de novo AML), and AAML1531 (Down syndrome AML), through a nursing perspective, with a focus on targeted and investigational agents, supportive care measures, and patient and family education.
- COG Session
- Total ILNA Points: 1
- ILNA Category: Care of the Pediatric Hematology and Oncology Patient
- ILNA Category: Treatment
- ILNA Category: Symptom Management
- ILNA Category: Psychosocial Dimension of Care
- ILNA Category: Supportive Care
- Intermediate Level
- Oncology
- Supportive Care
- Chemotherapy
- Concurrent Session
Related items
- Paper Presentation: Supportive Care/Quality Improvement — Beyond Words: Expressing Hope Through Creative Art Among Adolescents Who Have Advanced Cancer (216-3)
- Stopping the Flow: Management of Heavy Menstrual Bleeding and Menstrual Concerns in Adolescent Females with Bleeding and Clotting Disorders (226)
- General Session: Promoting Resilience in Children with Cancer and their Families (103)
- Navigating Ethics in Real World Pediatric Hematology/Oncology Nursing Practice (224)
- No Easy Target! What’s new in AML Therapy? (225)
- Speaker(s):
- Stephanie Cox, MN NP
- CNE Hours:
- 1
- RX Hours:
- 0.25